Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mutant double cyclized receptor peptides inhibiting β1-adrenoceptor antibodies

Mutant double cyclized receptor peptides inhibiting β1-adrenoceptor antibodies

US Patent 9062095 · Granted Jun 23, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Means for treating cardiovascular disease2022
Means and methods for the determination of camp in vitro and in vivo2014
Means and methods for the determination of camp in vitro and in vivo2014
Erk1/2 posphorylation site specific antibody2014
Means for the inhibition of anti-beta1-adrenergic receptor antibodies2014
Means for the inhibition of anti-beta1-adrenergic receptor antibodies2014
Means for the inhibition of anti-beta1-adrenergic receptor antibodies2014
Means for the inhibition of anti-β1-adrenergic receptor antibodies2014
Means for the inhibition of anti-β1-adrenergic receptor antibodies2014
Means for the inhibition of anti-β1-adrenergic receptor antibodies2014
Means for the inhibition of anti-β1-adrenergic receptor antibodies2012
Means for the inhibition of anti-β1-adrenergic receptor antibodies2012